Immunologic function and survival in hemodialysis patients - PubMed (original) (raw)

Comparative Study

Immunologic function and survival in hemodialysis patients

P L Kimmel et al. Kidney Int. 1998 Jul.

Abstract

Background: Although the medical determinants of mortality in patients with end-stage renal disease (ESRD) treated with hemodialysis (HD) are well appreciated, the contribution of immunologic parameters to survival in such patients is unclear, especially when variations in age, medical comorbidity and nutrition are controlled. In addition, although dysregulation of cytokine metabolism has been appreciated in patients with ESRD, the association of these parameters with outcomes has not been established. Recently, the type of dialyzer used in patients' treatment has been associated with survival, but the mechanisms underlying these findings, including their immune effects, have not been established. We conducted a prospective, cross-sectional, observational multicenter study of urban HD patients to determine the contribution of immunological factors to patient survival. We hypothesized increased proinflammatory cytokines would be associated with increased mortality, and that improved immune function would be associated with survival.

Methods: Patients were assessed using demographic and anthropometric indices, Kt/V, protein catabolic rate (PCR) and immunologic variables including circulating cytokine [interleukin (IL)-1, IL-2, IL-4, IL-5, IL-6, IL-12, IL-13 and tumor necrosis factor (TNF)-alpha] levels, total hemolytic complement activity (CH50), and T cell number and function. A severity index, previously demonstrated to be a mortality marker, was used to grade medical comorbidity. A Cox proportional hazards model, controlling for patients' age, severity index, level of serum albumin concentration, dialyzer type and dialysis site was used to asses relative survival risk.

Results: Two hundred and thirty patients entered the study. The mean (+/- SD) age of the population was 54.4 +/- 14.2 years, mean serum albumin concentration was 3.86 +/- 0.47 g/dl, mean PCR was 1.1 +/- 0.28 g/kg/day, and mean Kt/V 1.2 +/- 0.3. Patients' serum albumin concentration was correlated with levels of Kt/V and PCR, and their circulating IL-13 and TNF-alpha levels, but negatively with their circulating IL-2 levels, T-cell number and T-cell antigen recall function. T-cell antigen recall function correlated negatively with PCR, but not Kt/V. There was no correlation of any other immune parameter and medical or demographic factor. Immune parameters, were all highly intercorrelated. Mean level of circulating cytokines in HD patients were in all cases greater than those of a normal control group. There were few differences in medical risk factors or immune parameters between patients treated with different types of dialyzers. After an almost three-year mean follow-up period, increased IL-1, TNF-alpha, IL-6, and IL-13 levels were significantly associated with increased relative mortality risk, while higher levels of IL-2, IL-4, IL-5, IL-12, T-cell number and function, and CH50 were associated with improved survival. The difference in survival between patients treated with unmodified cellulose dialyzers and modified or synthetic dialyzers approached the level of statistical significance, but there were no differences in levels of circulating cytokines between these two groups.

Conclusions: Higher levels of circulating proinflammatory cytokines are associated with mortality, while immune parameters reflecting improved T-cell function are associated with survival in ESRD patients treated with HD, independent of other medical risk factors. These factors may serve as markers for outcome. The mechanism underlying the relationship of immune function and survival, and the effect of interventions to normalize immune function in HD patients should be studied.

PubMed Disclaimer

Figures

Fig. 1.

Fig. 1.. Distribution of immune parameters in 230 stable outpatients with end-stage renal disease (ESRD) treated with hemodialysis.

Distributions of IL-2 (A), CH50 (B), T-cell number (C) and T-cell function (D) show moderate skew (skewness values ranging from −0.45 to 0.33). These factors were associated with improved patient survival.

Fig. 2.

Fig. 2.. Distribution of immune parameters in 230 stable outpatients with ESRD treated with hemodialysis.

Highly positively skewed distributions of circulating IL-1 (A), IL-6 (B), TNF-α (C) and IL-13 (D) levels were noted in this population (skewness values ranging from 1.25 to 3.3). Most patients’ values were within a lower range, with a minority having extremely elevated values. These factors were associated with increased patient mortality.

Similar articles

Cited by

References

    1. Held PJ, Port FK, Webb RL, et al.: Excerpts from the United States Renal Data System 1996 Annual Report. Am JKidney Dis 28(Suppl): S79–S92, 1996
    1. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001–1006, 1993 - PubMed
    1. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458–482, 1990 - PubMed
    1. Lowrie EG, Laird M, Parker TF, Sargent JA: The effect of hemodialysis prescription on patient mortality. Report from the NCDS. N Engl J Med 32:382–389, 1981 - PubMed
    1. Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, Bloembergen WE, Greer JW, Hakim RM: The dose of hemodialysis and patient mortality. Kidney Int 50:550–556, 1996 - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources